X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (514) 514
Publication (33) 33
Book Review (17) 17
Book Chapter (6) 6
Conference Proceeding (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
golimumab (502) 502
index medicus (273) 273
humans (231) 231
infliximab (209) 209
adalimumab (200) 200
rheumatoid arthritis (159) 159
rheumatology (142) 142
antibodies, monoclonal - therapeutic use (132) 132
double-blind (122) 122
female (116) 116
ulcerative colitis (116) 116
male (115) 115
etanercept (112) 112
adult (101) 101
treatment outcome (96) 96
tumor necrosis factor-alpha - antagonists & inhibitors (94) 94
middle aged (93) 93
efficacy (87) 87
safety (87) 87
pharmacology & pharmacy (82) 82
antirheumatic agents - therapeutic use (78) 78
methotrexate (78) 78
arthritis, rheumatoid - drug therapy (76) 76
psoriatic arthritis (74) 74
arthritis (73) 73
therapy (73) 73
necrosis-factor-alpha (71) 71
certolizumab (65) 65
ankylosing spondylitis (61) 61
rheumatoid-arthritis (60) 60
inflammatory bowel disease (57) 57
antibodies, monoclonal - adverse effects (54) 54
certolizumab pegol (52) 52
antibodies, monoclonal - administration & dosage (51) 51
aged (47) 47
arthritis, psoriatic - drug therapy (45) 45
gastroenterology & hepatology (45) 45
phase-iii (44) 44
inflammatory-bowel-disease (43) 43
medicine & public health (43) 43
psoriasis (43) 43
severity of illness index (41) 41
clinical-response (40) 40
tocilizumab (40) 40
tumor necrosis factor (40) 40
vedolizumab (40) 40
ankylosing-spondylitis (38) 38
remission (38) 38
tumor necrosis factor-tnf (38) 38
abatacept (36) 36
biologics (36) 36
crohns-disease (36) 36
monoclonal antibodies (36) 36
monoclonal-antibody (36) 36
clinical trials (35) 35
patients (35) 35
colitis, ulcerative - drug therapy (34) 34
crohn's disease (34) 34
drug therapy, combination (34) 34
maintenance therapy (33) 33
multicenter (33) 33
antibodies, monoclonal - pharmacokinetics (32) 32
every 4 weeks (32) 32
spondylitis, ankylosing - drug therapy (32) 32
anti-tnf (31) 31
tnf inhibitors (31) 31
active rheumatoid-arthritis (30) 30
drug therapy (30) 30
inflammation (30) 30
young adult (30) 30
pharmacokinetics (29) 29
remission induction (29) 29
rheumatoid factor (29) 29
tumor-necrosis-factor (29) 29
analysis (28) 28
antirheumatic agents - administration & dosage (28) 28
internal medicine (28) 28
methotrexate - therapeutic use (28) 28
rituximab (28) 28
animals (27) 27
disease-activity (27) 27
double-blind method (27) 27
methotrexate therapy (27) 27
placebo-controlled trial (27) 27
ustekinumab (27) 27
immunology (26) 26
time factors (26) 26
care and treatment (25) 25
studies (25) 25
antibodies, monoclonal, humanized - therapeutic use (24) 24
disease progression (24) 24
tumor necrosis factor-alpha - immunology (24) 24
antibodies, monoclonal - pharmacology (23) 23
review (23) 23
anti-inflammatory agents - therapeutic use (22) 22
anti-tnf therapy (22) 22
antirheumatic agents - adverse effects (22) 22
antibody (21) 21
injections, subcutaneous (21) 21
medicine, general & internal (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (452) 452
Russian (15) 15
German (13) 13
Korean (10) 10
Spanish (10) 10
French (7) 7
Slovak (6) 6
Czech (3) 3
Japanese (3) 3
Hungarian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Rheumatology, ISSN 1439-7595, 07/2018, Volume 28, Issue 4, pp. 712 - 715
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 01/2018, Volume 36, Issue 1, pp. 140 - 143
Objective. Clinical data suggest that the response of rheumatoid arthritis patients to treatment with golimumab is much lower among those who switched from... 
Golimumab | Treatment | Cytokines | Adalimumab | Rheumatoid arthritis | treatment | cytokines | RHEUMATOLOGY | rheumatoid arthritis | adalimumab | golimumab
Journal Article
ARTHRITIS RESEARCH & THERAPY, ISSN 1478-6354, 08/2019, Volume 21, Issue 1, pp. 190 - 9
Journal Article
JOURNAL OF RHEUMATOLOGY, ISSN 0315-162X, 10/2019, Volume 46, Issue 10, pp. 1277 - 1283
Objective. Evaluate safety and efficacy of intravenous (IV) golimumab (GOL) in patients with active ankylosing spondylitis (AS) through 1 year. Methods. A... 
RECOMMENDATIONS | GOLIMUMAB | PREFERENCES | ANTI-TUMOR NECROSIS FACTOR THERAPY | IMPROVEMENT | ANKYLOSING SPONDYLITIS | RHEUMATOLOGY | BIOLOGICS | BATH | INTRAVENOUS
Journal Article
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, ISSN 0392-856X, 05/2019, Volume 37, Issue 3, pp. 367 - 372
Objective To investigate ex-vivo drug-inhibited cytokine production before the start of a biological DMARD (bDMARD) as predictor of treatment response in... 
CELLS | ADALIMUMAB | bDMARD | biomarkers | GOLIMUMAB | prediction of response | cytokines | RHEUMATOLOGY | rheumatoid arthritis | DISEASE-ACTIVITY
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 6/2015, Volume 34, Issue 6, pp. 1141 - 1143
We report on a patient with a long-standing history of recurrent oral aphthosis and pseudofolliculitis, diagnosed with Behçet’s disease (BD), previously... 
Golimumab | Medicine & Public Health | Oral aphthosis | Tocilizumab | Rheumatology | Genital ulcers | Behçet’s disease (BD)
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2015, Volume 82, Issue 6, pp. 424 - 425
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 9/2017, Volume 36, Issue 9, pp. 2063 - 2069
Our aim was to retrospectively assess the role of golimumab as a treatment choice in patients with Behçet’s disease (BD). Seventeen patients diagnosed with BD... 
Golimumab | Disease activity | Medicine & Public Health | Autoinflammatory disease | TNF-α | Biologics | Rheumatology | Behçet’s disease
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2017, Volume 47, Issue 1, pp. 108 - 114
Journal Article
Survey of Ophthalmology, ISSN 0039-6257, 2015, Volume 60, Issue 6, pp. 575 - 589
Since the first reported use in 2001 of an anti-tumor necrosis factor-alpha (TNF-α) agent, infliximab, for the treatment of uveitis, several new anti-TNF-α... 
Golimumab | Therapy | Tumor necrosis factor-alpha | Etanercept | Infliximab | Certolizumab | Pharmacogenomics of anti-TNF-α | Uveitis | Adalimumab | Anti-drug antibodies | Serum levels of anti-TNF-α drug
Journal Article
Ocular Immunology and Inflammation, ISSN 0927-3948, 01/2019, Volume 27, Issue 1, pp. 58 - 63
Purpose: To evaluate golimumab (GOL) efficacy in the management of Behçet's disease (BD)-related uveitis. Methods: We retrospectively collected data from 5... 
intraocular inflammation | retinal vasculitis | Behçet's disease | uveitis | golimumab | OPHTHALMOLOGY | Behcet's disease
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 07/2011, Volume 65, Issue 1, pp. 137 - 174
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.